Oncology & Cancer
Big data to help blood cancer patients
A pioneering database at the University of Leeds will help match patients with certain types of blood cancers to the best treatments.
May 20, 2014
0
0
News tagged with lymphoma patients
Oncology & Cancer
New investigational epigenetic therapy shows clinical activity against several blood cancers
Patients with a variety of hematological, or blood, cancers benefited from treatment with OTX015, a member of a new class of investigational epigenetic therapies that block the activity of bromodomain and extraterminal (BET)-bromodomain ...
Apr 8, 2014
0
0
Oncology & Cancer
Study finds pill may represent promising treatment for stubborn blood cancers
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* ...
Mar 10, 2014
0
0
Oncology & Cancer
Low-intensity therapy for Burkitt lymphoma is highly effective, study finds
Adult patients with a type of cancer known as Burkitt lymphoma had excellent long-term survival rates—upwards of 90 percent—following treatment with low-intensity chemotherapy regimens, according to a new clinical trial ...
Nov 13, 2013
0
1
Oncology & Cancer
Redefining the criteria for ALK positive lung cancer
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. ...
Sep 10, 2013
0
0
Oncology & Cancer
Study links Hodgkin lymphoma treatment to possible risk of stomach cancer
(Medical Xpress)—Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer ...
Aug 27, 2013
0
0
Oncology & Cancer
HIV-associated lymphoma survival has not improved during the antiretroviral therapy era
Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute.
Jul 27, 2013
0
0
Oncology & Cancer
Researchers exploit cancer's faulty defence mechanism
Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.
Jun 13, 2013
0
0
Oncology & Cancer
Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
May 13, 2013
0
0
Oncology & Cancer
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
May 1, 2013
0
0
